Mounjaro vs Ozempic: Key Differences at a Glance
Mounjaro (tirzepatide) and Ozempic (semaglutide) are both injectable GLP-1 medications used for weight loss, but they are not the same drug. Ozempic targets one receptor (GLP-1), while Mounjaro targets two (GLP-1 and GIP) — making it a dual-agonist with a broader metabolic effect. Both are FDA-approved for type 2 diabetes. Ozempic's weight-loss version is Wegovy; Mounjaro's is Zepbound. Understanding how GLP-1 medications work helps explain why these differences matter.
How They Work Differently in the Body
Ozempic (semaglutide) mimics the GLP-1 hormone, slowing gastric emptying, reducing appetite, and improving insulin sensitivity. Mounjaro (tirzepatide) does all of this AND activates GIP receptors, which provide additional metabolic benefits including enhanced fat burning and improved nutrient processing. This dual mechanism is why Mounjaro consistently outperforms Ozempic in clinical trials. For a deeper comparison of the active ingredients, see our tirzepatide vs semaglutide guide.
Weight Loss Results: Clinical Trial Data
The clinical data is clear. In the SURMOUNT trials, Mounjaro (tirzepatide) patients lost up to 22.5% of their body weight at the highest dose over 72 weeks. In the STEP trials, Ozempic/Wegovy (semaglutide) patients lost approximately 15% of body weight over 68 weeks. For a 200-pound person, that's roughly 45 lbs with Mounjaro vs 30 lbs with Ozempic. Both significantly outperform older weight loss medications and lifestyle changes alone. Read our semaglutide results timeline for week-by-week expectations.
Dosing Schedule and Administration
Both are once-weekly injections administered subcutaneously (typically in the abdomen, thigh, or upper arm). Ozempic starts at 0.25 mg and titrates up to a maximum of 2 mg. Mounjaro starts at 2.5 mg and can increase to 15 mg. Both follow a gradual dose escalation to minimize side effects — typically increasing every 4 weeks. The injection process is similar for both and takes only seconds. Most patients describe it as quick and nearly painless. For details on what the first month looks like, see our first month guide.
What To Know Before Starting GLP-1 Treatment
Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.
GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.
That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.
Side Effects Compared
Both medications share the same primary side effects: nausea, vomiting, diarrhea, and constipation. These are most common during dose escalation and typically improve over time. In clinical trials, Mounjaro had slightly higher rates of certain GI symptoms at its highest doses (15 mg), but at comparable doses, tolerability was similar. Serious but rare side effects for both include pancreatitis and gallbladder problems. Both carry a boxed warning about thyroid C-cell tumors (observed in animal studies only). For detailed management strategies, read our side effects guide.
Cost: Brand-Name vs Compounded
At retail price without insurance, Ozempic costs approximately $900–$1,000/month and Mounjaro costs approximately $1,000–$1,100/month. Their weight-loss specific versions (Wegovy and Zepbound) are even more expensive at $1,000–$1,400/month. However, most patients access these medications through telehealth providers offering compounded versions at a fraction of the cost: compounded semaglutide from $199/month and compounded tirzepatide from $300–$500/month. Both typically include medical consultations and home delivery. For a detailed cost breakdown, see our semaglutide monthly cost guide and full pricing comparison.
Insurance Coverage
Insurance coverage varies significantly for both medications. Ozempic tends to have better insurance coverage because it's classified as a diabetes drug with a longer track record. Mounjaro also has diabetes coverage. However, when prescribed specifically for weight loss (without a diabetes diagnosis), both medications are frequently excluded from formularies. Wegovy and Zepbound face even more coverage barriers. For most patients paying out of pocket, compounded versions through telehealth providers are the most practical path. See our guide on getting weight loss medication without insurance.
Can You Get Mounjaro or Ozempic Online?
Yes — both are available through licensed telehealth providers without in-person doctor visits. The process typically involves an online health evaluation, physician review, prescription, and home delivery within 3–7 days. Most telehealth providers offer compounded versions of both semaglutide and tirzepatide. Some providers offer both medications, while others specialize in one. Compare providers that offer the medication you're interested in, or take our matching quiz for a personalized recommendation. For a step-by-step walkthrough, read our guide on how to get Ozempic online.
Who Should Choose Mounjaro?
Mounjaro may be the better choice if you have significant weight to lose (50+ lbs), want the highest average weight loss based on clinical data, are interested in the dual-agonist mechanism, have type 2 diabetes alongside weight loss goals, or have tried semaglutide and hit a plateau. Mounjaro's dual mechanism provides additional metabolic benefits that some patients respond to better than semaglutide alone.
Who Should Choose Ozempic?
Ozempic/semaglutide may be the better choice if you prefer a medication with a longer track record and more real-world data, want the broadest availability through telehealth providers (compounded semaglutide is more widely available than compounded tirzepatide), are looking for the lowest cost option (compounded semaglutide starts around $199/month vs $300+ for tirzepatide), or have insurance that covers Ozempic but not Mounjaro.
Can You Switch Between Mounjaro and Ozempic?
Yes, switching between semaglutide and tirzepatide is possible and relatively common. Some patients start with Ozempic/semaglutide and switch to Mounjaro/tirzepatide if they plateau or want stronger results. Others may switch from tirzepatide to semaglutide for cost reasons. Switching should always be done under medical supervision — your provider will determine the appropriate starting dose of the new medication. Most telehealth providers can manage this transition as part of their ongoing care.
The Bottom Line: Mounjaro vs Ozempic
Both Mounjaro and Ozempic are proven, effective weight loss medications. Mounjaro has a clinical edge in average weight loss (22% vs 15%), while Ozempic has a longer track record, wider compounded availability, and lower compounded pricing. The best choice depends on your weight loss goals, budget, insurance situation, and how your body responds. Many patients find success with either option. The most important step is getting started with a licensed provider who can guide your treatment. Take our matching quiz to find the right provider for your needs, or compare all providers side by side.